1951
DOI: 10.1136/bjo.35.10.601
|View full text |Cite
|
Sign up to set email alerts
|

Trachoma : Diagnosis and Treatment

Abstract: MEDICAL treatment has undergone revolutionary changes since the recent discovery of many new therapeutic agents, and this progress has been fully shared by ophthalmology. Such advances have unfortunately been accompanied by the appearance, in both scientific and popular periodicals, of quite incredible claims for the therapeutic effect of certain remedies. Trachoma, a widespread and incapacitating disease, has been the subject of many such communications, and surgeons with a limited experience of the condition… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1951
1951
2017
2017

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…Other early studies of note were focused on neonatal conjunctivitis and its treatment [ 5 7 ] as well as gonococcal and tuberculous eye infections [ 7 , 8 ]. The majority of reports at that time were observational studies of clinical cases and outcomes following treatment with penicillin, sulphonamides, or newer antibiotics such as tetracyclines and macrolides [ 1 – 3 , 5 , 9 – 14 ]. Since that time, studies of ocular bacterial infections expanded to address the mechanisms of pathogenesis and the inflammatory response in a so-called “immune-privileged” site.…”
Section: Introductionmentioning
confidence: 99%
“…Other early studies of note were focused on neonatal conjunctivitis and its treatment [ 5 7 ] as well as gonococcal and tuberculous eye infections [ 7 , 8 ]. The majority of reports at that time were observational studies of clinical cases and outcomes following treatment with penicillin, sulphonamides, or newer antibiotics such as tetracyclines and macrolides [ 1 – 3 , 5 , 9 – 14 ]. Since that time, studies of ocular bacterial infections expanded to address the mechanisms of pathogenesis and the inflammatory response in a so-called “immune-privileged” site.…”
Section: Introductionmentioning
confidence: 99%